Skip to Main Content

Paper Details

Na<sup>+</sup>/H<sup>+</sup>-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cells.
Cancer Res Commun
1
2022
) cell, CA9, H, NHE1, NK, NK-92, Na, Na/H, Na/H-exchanger 1, PD1, RHEB, antitumor, c, c-Myc, carbonic anhydrase IX, engineered NK-92 natural killer cells, hematological malignancies, hepatocellular carcinoma, human, human NK cell line NK-92, immune effector cells, mTOR complex 1, mTORC1, natural killer, solid tumors, tumor
Author NameAffiliation
Chi V DangThe Wistar Institute
Chi V DangLudwig Institute for Cancer Research
Chi V DangThe Wistar Institute
Chi V DangLudwig Institute for Cancer Research
  • 1 - 4

Datasets

Release 1.2